Patent · US Active

Medical treatment for pathologic inflammation

US11896564B2 · kind B2 · utility

0Cited by

3References

23Claims

0Family size

Assignee

PHARMACYL AB · SE

Inventors

Gunnar Hedlund · Lund, SE
Anders Bjork · Bjärred, SE

Key dates

Filing date	Aug 15, 2019
Grant date	Feb 13, 2024
Priority date	—
Expiry date	Feb 5, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, for use in combination with a 5-ASA agent, in the treatment of a disease resulting from pathologic inflammation. The combination of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof and 5-ASA agent and use of such combination. A kit-of-parts and a pharmaceutical composition comprising such a combination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.